Prescription drug · ANDA
Dexamethasone NDC 71205-703
Dexamethasone 4 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71205-703-20 | 71205070320 | 20 TABLET in 1 BOTTLE (71205-703-20)Marketed from Oct 4, 2022 | |
| 71205-703-30 | 71205070330 | 30 TABLET in 1 BOTTLE (71205-703-30)Marketed from Oct 4, 2022 | |
| 71205-703-60 | 71205070360 | 60 TABLET in 1 BOTTLE (71205-703-60)Marketed from Oct 4, 2022 | |
| 71205-703-90 | 71205070390 | 90 TABLET in 1 BOTTLE (71205-703-90)Marketed from Oct 4, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dexamethasone
- Generic name (nonproprietary)
- dexamethasone
- Active ingredients
- Dexamethasone — 4 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 088481
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 71205-703_6f917c55-034a-40c5-9011-0e10e94d0ebaSPL ID 6f917c55-034a-40c5-9011-0e10e94d0ebaSPL set ID 6f917c55-034a-40c5-9011-0e10e94d0ebaRxCUI 197582UNII 7S5I7G3JQLUPC 0371205703202
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471205070320followed by a unit qualifier and the quantityPackage 71205-0703-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis and serum sickness. Dermatologic Diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoi…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 088481
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-2108 |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | Alvogen Inc. | 47781-914 |
| Dexamethasone | Dexamethasone 6 mg/1 | TabletOral | Alvogen Inc. | 47781-916 |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0328 |
| Dexamethasone | Dexamethasone 4 mg/1 | TabletOral | Redpharm Drug, Inc. | 67296-1837 |